TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
CVS Health ( (CVS) ) has provided an update.
On December 9, 2025, CVS Health held its 2025 Investor Day, where it updated its financial guidance for 2025 and provided projections for 2026, highlighting a strategic focus on transforming consumer experiences and leveraging its enterprise capabilities. The company aims for a mid-teens Adjusted EPS CAGR through 2028 and announced a new open consumer engagement platform to simplify care and improve health. This strategic direction is expected to enhance CVS Health’s role in the healthcare sector, offering significant value to stakeholders and positioning the company as a central player in shaping the future of healthcare.
The most recent analyst rating on (CVS) stock is a Buy with a $87.00 price target. To see the full list of analyst forecasts on CVS Health stock, see the CVS Stock Forecast page.
Spark’s Take on CVS Stock
According to Spark, TipRanks’ AI Analyst, CVS is a Neutral.
CVS Health’s overall stock score is driven by stable financial performance and strong earnings call results, despite technical and valuation challenges. The company’s strategic initiatives and leadership changes are positive, but the high P/E ratio and Omnicare’s financial issues pose risks.
To see Spark’s full report on CVS stock, click here.
More about CVS Health
CVS Health is a leading health solutions company with over 9,000 retail pharmacy locations, more than 1,000 walk-in and primary care medical clinics, and a prominent pharmacy benefits manager serving approximately 87 million plan members. The company provides health insurance products and services to over 37 million people, including Medicare Advantage offerings and a standalone Medicare Part D prescription drug plan. CVS Health’s integrated model leverages personalized, technology-driven services to enhance access to quality care, improve outcomes, and reduce costs.
Average Trading Volume: 7,433,338
Technical Sentiment Signal: Strong Buy
Current Market Cap: $96.01B
For detailed information about CVS stock, go to TipRanks’ Stock Analysis page.